Effects of full spectrum illumination on post-stroke depression and sleep quality

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900026231

Enrollment

Unknown

Registered

2019-09-28

Start date

2019-10-01

Completion date

Unknown

Last updated

2019-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-stroke Depression and Sleep Quality

Interventions

A:LED lamp lighting and oral chlorhexidine

B:Full Spectrum Illumination and Oral Chloroxetine

C:Full Spectrum Illumination

D:LED lamp lighting

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Stroke was diagnosed by magnetic resonance and CT in all patients; 2. liver and kidney function were normal; 3. voluntary participate in the research.

Exclusion criteria

Exclusion criteria: 1. Progressive cerebral infarction, massive infarction or massive hemorrhage, subarachnoid hemorrhage, ventricular hemorrhage, TIA; 2. aphasia, severe dementia, communication disorders; 3. combined with other serious diseases; 4. with a history of psychiatric illness; 5. had a history of alcohol abuse, long-term coffee or tea drinking; 6. it was difficult to understand the content of the research scale; 7. complicated with ophthalmic diseases, such as retinopathy, glaucoma; 8. contraindications for phototherapy; 9. with a history of drug allergy; 10. with a history of epilepsy; 11. with depression or insomnia symptoms before stroke; 12. other factors led to sleep disorders; 13. other factors could not comply with the requirements of the experiment.

Design outcomes

Primary

Measure	Time frame
HADM;	—

Countries

China

Contacts

Public ContactJianmin Hu

The Second Affiliated Hospital of Fujian Medical University

doctorhjm@163.com+86 15359595888

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026